Literature DB >> 2495370

Influenza C virus esterase: analysis of catalytic site, inhibition, and possible function.

R Vlasak1, T Muster, A M Lauro, J C Powers, P Palese.   

Abstract

The active site serine of the acetylesterase of influenza C virus was localized to amino acid 71 of the hemagglutinin-esterase protein by affinity labeling with 3H-labeled diisopropylfluorophosphate. This serine and the adjacent amino acids (Phe-Gly-Asp-Ser) are part of a consensus sequence motif found in serine hydrolases. Since comparative analysis failed to reveal esterase sequence similarities with other serine hydrolases, we suggest that this viral enzyme is a serine hydrolase constituting a new family of serine esterases. Furthermore, we found that the influenza C virus esterase was inhibited by isocoumarin derivatives, with 3,4-dichloroisocoumarin being the most potent inhibitor. Addition of this compound prevented elution of influenza C virus from erythrocytes and inhibited virus infectivity, possibly through inhibition of virus entry into cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495370      PMCID: PMC250621     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence.

Authors:  M Schumacher; S Camp; Y Maulet; M Newton; K MacPhee-Quigley; S S Taylor; T Friedmann; P Taylor
Journal:  Nature       Date:  1986 Jan 30-Feb 5       Impact factor: 49.962

2.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

Authors:  P Palese; K Tobita; M Ueda; R W Compans
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

3.  On the homology of the active-site peptides of liver carboxylesterases.

Authors:  R C Augusteyn; J de Jersey; E C Webb; B Zerner
Journal:  Biochim Biophys Acta       Date:  1969-01-07

4.  An x-ray crystallographic study of the binding of peptide chloromethyl ketone inhibitors to subtilisin BPN'.

Authors:  J D Robertus; R A Alden; J J Birktoft; J Kraut; J C Powers; P E Wilcox
Journal:  Biochemistry       Date:  1972-06-20       Impact factor: 3.162

5.  Subtilisin Carlsberg. V. The complete sequence; comparison with subtilisin BPN'; evolutionary relationships.

Authors:  E L Smith; R J DeLange; W H Evans; M Landon; F S Markland
Journal:  J Biol Chem       Date:  1968-05-10       Impact factor: 5.157

6.  A comparison of "influenza C" with prototype myxoviruses: receptor-destroycing activity (neuraminidase) and structural polypeptides.

Authors:  A P Kendal
Journal:  Virology       Date:  1975-05       Impact factor: 3.616

7.  Galanthamine chemistry. VII. Synthesis of analogues of galanthamine.

Authors:  S Uyeo; H Shirai; A Koshiro; T Yashiro; K Kagei
Journal:  Chem Pharm Bull (Tokyo)       Date:  1966-09       Impact factor: 1.645

8.  Reaction of serine proteases with substituted 3-alkoxy-4-chloroisocoumarins and 3-alkoxy-7-amino-4-chloroisocoumarins: new reactive mechanism-based inhibitors.

Authors:  J W Harper; J C Powers
Journal:  Biochemistry       Date:  1985-12-03       Impact factor: 3.162

9.  The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase.

Authors:  G Herrler; R Rott; H D Klenk; H P Müller; A K Shukla; R Schauer
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

10.  The relationship of the receptors of a new strain of virus to those of the mumps-NDV-influenza group.

Authors:  G K HIRST
Journal:  J Exp Med       Date:  1950-02       Impact factor: 14.307

View more
  25 in total

1.  The hemagglutinin/esterase glycoprotein of bovine coronaviruses: sequence and functional comparisons between virulent and avirulent strains.

Authors:  X M Zhang; K G Kousoulas; J Storz
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

2.  Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence.

Authors:  Lubna Kazi; Arjen Lissenberg; Richard Watson; Raoul J de Groot; Susan R Weiss
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro.

Authors:  A Lissenberg; M M Vrolijk; A L W van Vliet; M A Langereis; J D F de Groot-Mijnes; P J M Rottier; R J de Groot
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Structure and orientation of expressed bovine coronavirus hemagglutinin-esterase protein.

Authors:  T E Kienzle; S Abraham; B G Hogue; D A Brian
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Hemagglutinin-esterase, a novel structural protein of torovirus.

Authors:  L A Cornelissen; C M Wierda; F J van der Meer; A A Herrewegh; M C Horzinek; H F Egberink; R J de Groot
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Identification of a coronavirus hemagglutinin-esterase with a substrate specificity different from those of influenza C virus and bovine coronavirus.

Authors:  A Klausegger; B Strobl; G Regl; A Kaser; W Luytjes; R Vlasak
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  The hemagglutinin-esterase of mouse hepatitis virus strain S is a sialate-4-O-acetylesterase.

Authors:  G Regl; A Kaser; M Iwersen; H Schmid; G Kohla; B Strobl; U Vilas; R Schauer; R Vlasak
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Expression and secretion of the bovine coronavirus hemagglutinin-esterase glycoprotein by insect cells infected with recombinant baculoviruses.

Authors:  M D Parker; D Yoo; L A Babiuk
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

9.  Infectious salmon anemia virus specifically binds to and hydrolyzes 4-O-acetylated sialic acids.

Authors:  Audny Hellebø; Ulrike Vilas; Knut Falk; Reinhard Vlasak
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Identification and characterization of viral structural proteins of infectious salmon anemia virus.

Authors:  Knut Falk; Vidar Aspehaug; Reinhard Vlasak; Curt Endresen
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.